![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj6e_r4o5sbNKs1DdnmHJvbtV-6Z-LAdWyjDwc29A8uDeV8yprTYPl3w8DqkdeoHRAtweLBijS3og9A76v2fKJSLHANYWR3IPexiSabN9PmPBDocVAx5O3JkBoN9wMXnJW8bUhKrJ8B8LM/s320/cplogo08.jpg)
MattsonJack Vice President Lee Blansett addresses the issue of Value-Based Pricing for Oncology Drugs, Including the Role of Biomarkers in Pricing - Will They Help to Set Price Points, Affect Reimbursement?
Click here for more details on the program.
No comments:
Post a Comment